Equities research analysts expect Health Insurance Innovations (NASDAQ:HIIQ) to announce sales of $69.14 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Health Insurance Innovations’ earnings. The lowest sales estimate is $66.50 million and t
U.S. equities continued their post-election, pre-holiday climb on Tuesday with the Dow Jones Industrial Average inching ever closer to the 20,000 threshold. News flow was light, focused on terror attacks in Europe and the prospect of fiscal policy easing from the incoming Trump Administration.
In the end, the Dow gained 0.5%, the S&P 500 gained 0.4%, the Nasdaq Composite wafted....More>>>
The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with big potential upside and big potential downside.
As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies.....More>>>
Apple Inc. (NSDQ:AAPL)hasn’t been having its own way recently. A few months ago, the company wasordered to return $13 billion in back taxes in Europe plus now it has todeal with a new US president in Donald Trumpwho clearly has reservationson how Apple runs its business affairs. Recently though, the Irish government announced that it would be appealing the European Commission’s decision....More>>>
Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health care agencies, such as the U.S. Food and Drug Administration (FDA), can make or break these companies.
Analysts often weigh in on these companies, and there are a number of factors that play a role in how analysts view....More>>>
With Social Security funding issues around the corner, uncertain market conditions, long-term low interest rates and skyrocketing medical costs, American retirees are facing a laundry list of retirement challenges. The only certainty is that retirement is going to be dramatically different than the retirement previous generations encountered. In order to retire with financial security and dignity,....More>>>
Growth versus value investing is one of the major debates in the investment world. Growth stocks seem to have outperformed their value counterparts over the past few years. But the winning streak of growth investing took a hit this year with value stocks regaining lost glory.
It is currently speculated that value investing will likely continue its winning run in the upcoming years.....More>>>
Today, our Under the Radar Moversnewsletter suggestedsmall cap advanced materials stockIntermolecular Inc (NASDAQ: IMI) as a buy for our short-term trading portfolio:
Intermolecular has had a rather rough 2016, but things started to change last month, and things took a decided turn for the best today in the form of a push up and off the 50-day moving average line (purple) and above the 100-day....More>>>
EQT Corporation (NYSE:EQT) has announced that it has acquired Rice Energy Inc (NYSE:RICE) for $6.7 billion.
The new company unites both providers of natural gas to create a new EQT that is in a “position that will be unmatched in the industry,” said Steve Schlotterbeck, EQT’s president and chief executive officer.
Venezuela looks set to have the lowest voter participation for a presidential election in at least two decades after opposition supporters heeded a boycott call and disillusioned government supporters stayed home.
Yet, two hours after the expected close of voting centers, many remained ope
DekaBank Deutsche Girozentrale purchased a new position in Iovance Biotherapeutics (NASDAQ:IOVA) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 42,400 shares of the biotechnology company’s stock,
The semiconductor industry is growing fast. Driven by a world of connected things, chip makers are finding a multitude of new applications for their wares, from wearables to industrial equipment to cars. Even in such a market, though, investing in semiconductors is a bumpy ride.